Home/Blog

Notes from the team — shorter, stranger, in-progress.

Methodology debates, follow-up reporting, field notes from shelf surveys, and the occasional rant. Not the same as a Guide — these are working drafts of our thinking.

🔍

No posts match that search.

Try a different keyword or clear the filter.
More posts
BS

Behind the score: how a 7.5 became a 6.1 in 14 days.

A walkthrough of the HK Vitals iron-form change. The brand didn't announce it; we caught it on a routine batch re-test. What our triggers do and where they nearly missed it.

Behind the score · 11 Apr 2026
RD

Reading list — five papers that changed our position on melatonin.

The dose-response question is more settled than the Indian shelf admits. Five papers, two methodology reviews, and one short rant about 10mg gummies.

Reading · 5 Apr 2026
FN

What we found in the bottom drawer of a Bengaluru pharmacy.

Six expired-but-on-sale products, two grey-market import boxes, one unmarked white jar. A short essay on what shelf surveys don't capture.

Field notes · 1 Apr 2026
M

The "clinical dose" question we keep arguing about internally.

When trials disagree by 2× on what the studied dose is, which one anchors our rubric? Three reviewers, three different opinions, one published rule.

Methodology · 27 Mar 2026
BS

Behind the score: the curcumin row we couldn't agree on.

Three reviewers, four bioavailability technologies, and one decision about how to score a product whose effect is real but tiny per rupee.

Behind the score · 22 Mar 2026
RD

Reading list — what we're following on plant proteins this quarter.

Pea, soy, rice, hemp, and the leucine-threshold question. Six papers and one ongoing trial we'll be checking in on.

Reading · 17 Mar 2026
FN

Three things every fish-oil bottle tells you, and one it hides.

A photo essay of the back-of-bottle: serving sizes, EPA/DHA totals, and the freshness-marker that's never on the label.

Field notes · 11 Mar 2026
Older posts